ARMATA PHARMACEUTICALS INC's ticker is ARMP and the CUSIP is 04216R102. A total of 20 filers reported holding ARMATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,713 | +163.1% | 571 | 0.0% | 0.00% | – |
| Q2 2023 | $651 | -31.8% | 571 | 0.0% | 0.00% | – |
| Q1 2023 | $954 | +34.7% | 571 | 0.0% | 0.00% | – |
| Q4 2022 | $708 | -64.6% | 571 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 571 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 571 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 571 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | +50.0% | 571 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 571 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 571 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 571 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 571 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 571 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 571 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 571 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 571 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 571 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | – | 571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 160,382 | $481,146 | 0.01% |
| SeaCrest Wealth Management, LLC | 18,130 | $54,390 | 0.01% |
| Edgewood Management | 100,000 | $300,000 | 0.00% |
| Trifecta Capital Advisors, LLC | 714 | $2,142 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,577 | $16,731 | 0.00% |
| ROYAL BANK OF CANADA | 18 | $0 | 0.00% |
| VANGUARD GROUP INC | 90,969 | $272,907 | 0.00% |
| UBS Group AG | 2,249 | $6,747 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 571 | $1,713 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11,472 | $34,416 | 0.00% |